Literature DB >> 10359119

NF-kappaB-mediated self defense of macrophages faced with bacteria.

M Kitamura1.   

Abstract

NF-kappaB is a ubiquitous transcription factor that is extensively exploited by immune cells involved in host defense mechanisms. Macrophages participate in the first line of defense against microorganisms, but little is known about whether and how NF-kappaB is involved in the handling of microbes by macrophages. To explore this issue, NF-kappaB-inactive macrophages, NIKMAC(NR), were created by overexpression of a super-repressor mutant of IkappaB alpha. When co-cultured with Escherichia coli, the NIKMAC(NR) macrophages exhibited impairment of bactercidal activity. Microscopic analysis revealed that NIKMAC(NR) cells faced with bacteria underwent rapid and fulminant apoptosis. Similary, NIKMAC(NR) macrophages cultured in the presence of a bacterial component, lipopolysaccharide, showed dramatic apoptosis. Inhibition of RNA synthesis or protein synthesis failed to block the apoptosis of NIKMAC(NR) cells, indicating that macrophages possess a pre-existing, apoptotic pathway that can be triggered by bacteria. Apoptosis was not observed in NIKMAC(NR) macrophages exposed to non-microbial stimuli including phorbol ester and opsonized zymosan. However, NIKMAC(NR) cells were more susceptible to apoptosis triggered by TNF-alpha and reactive oxygen intermediates, both of which are produced abundantly by macrophages when faced with bacteria. These data suggest a critical role for NF-kappaB in the survival of macrophages at the site of bacterial infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10359119     DOI: 10.1002/(SICI)1521-4141(199905)29:05<1647::AID-IMMU1647>3.0.CO;2-Y

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

Review 1.  Host-pathogen interactions: subversion and utilization of the NF-kappa B pathway during infection.

Authors:  C M Tato; C A Hunter
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

Review 2.  NF-kappaB family of transcription factors: central regulators of innate and adaptive immune functions.

Authors:  Jorge Caamaño; Christopher A Hunter
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

3.  Escherichia coli prevents phagocytosis-induced death of macrophages via classical NF-kappaB signaling, a link to T-cell activation.

Authors:  Heinrich V Groesdonk; Silke Schlottmann; Friederike Richter; Michael Georgieff; Uwe Senftleben
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

4.  The apoptotic signaling pathway activated by Toll-like receptor-2.

Authors:  A O Aliprantis; R B Yang; D S Weiss; P Godowski; A Zychlinsky
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

5.  Arginine-143 of Yersinia enterocolitica YopP crucially determines isotype-related NF-kappaB suppression and apoptosis induction in macrophages.

Authors:  K Ruckdeschel; K Richter; O Mannel; J Heesemann
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

6.  Leishmania major amastigotes induce p50/c-Rel NF-kappa B transcription factor in human macrophages: involvement in cytokine synthesis.

Authors:  Lamia Guizani-Tabbane; Khadija Ben-Aissa; Meriam Belghith; Atfa Sassi; Koussay Dellagi
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

7.  Lipopolysaccharide desensitization of macrophages provides protection against Yersinia enterocolitica-induced apoptosis.

Authors:  Klaus Ruckdeschel; Kathleen Richter
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

8.  Salmonella-induced caspase-2 activation in macrophages: a novel mechanism in pathogen-mediated apoptosis.

Authors:  V Jesenberger; K J Procyk; J Yuan; S Reipert; M Baccarini
Journal:  J Exp Med       Date:  2000-10-02       Impact factor: 14.307

9.  Infection-induced bystander-apoptosis of monocytes is TNF-alpha-mediated.

Authors:  Stephan Dreschers; Christian Gille; Martin Haas; Julia Grosse-Ophoff; Marion Schneider; Anja Leiber; Hans-Jörg Bühring; Thorsten W Orlikowsky
Journal:  PLoS One       Date:  2013-01-17       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.